Global and United States Antihypertensive Drugs Market Insights, Forecast to 2027
SKU ID : QYR-18984751 | Publishing Date : 25-Aug-2021 | No. of pages : 149
Detailed TOC of Global and United States Antihypertensive Drugs Market Insights, Forecast to 2027
1 Study Coverage1.1 Antihypertensive Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Antihypertensive Drugs Market Size Growth Rate by Type
1.2.2 Diuretic Antihypertensive
1.2.3 Sympathetic Suppressant
1.2.4 Renin-angiotensin System Inhibitor
1.2.5 Calcium Antagonist Medicine
1.2.6 vasodilator
1.3 Market by Application
1.3.1 Global Antihypertensive Drugs Market Size Growth Rate by Application
1.3.2 The Old
1.3.3 Pregnant Woman
1.3.4 General Patient
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antihypertensive Drugs Market Size, Estimates and Forecasts
2.1.1 Global Antihypertensive Drugs Revenue 2016-2027
2.1.2 Global Antihypertensive Drugs Sales 2016-2027
2.2 Global Antihypertensive Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Antihypertensive Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Antihypertensive Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Antihypertensive Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Antihypertensive Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Antihypertensive Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Antihypertensive Drugs Revenue Forecast by Region (2022-2027)
3 Global Antihypertensive Drugs Competitor Landscape by Players
3.1 Global Top Antihypertensive Drugs Manufacturers by Sales
3.1.1 Global Antihypertensive Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Antihypertensive Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Antihypertensive Drugs Manufacturers by Revenue
3.2.1 Key Antihypertensive Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Antihypertensive Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Antihypertensive Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Antihypertensive Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Antihypertensive Drugs Revenue in 2020
3.2.6 Global Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antihypertensive Drugs Price by Manufacturers
3.4 Global Antihypertensive Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antihypertensive Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antihypertensive Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antihypertensive Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Antihypertensive Drugs Market Size by Type (2016-2021)
4.1.1 Global Antihypertensive Drugs Sales by Type (2016-2021)
4.1.2 Global Antihypertensive Drugs Revenue by Type (2016-2021)
4.1.3 Antihypertensive Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Antihypertensive Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Antihypertensive Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Antihypertensive Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Antihypertensive Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Antihypertensive Drugs Market Size by Application (2016-2021)
5.1.1 Global Antihypertensive Drugs Sales by Application (2016-2021)
5.1.2 Global Antihypertensive Drugs Revenue by Application (2016-2021)
5.1.3 Antihypertensive Drugs Price by Application (2016-2021)
5.2 Antihypertensive Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Antihypertensive Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Antihypertensive Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Antihypertensive Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Antihypertensive Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Antihypertensive Drugs Sales YoY Growth 2016-2027
6.1.2 United States Antihypertensive Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Antihypertensive Drugs Market Share in Global Market 2016-2027
6.2 United States Antihypertensive Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Antihypertensive Drugs Players by Sales (2016-2021)
6.2.2 United States Top Antihypertensive Drugs Players by Revenue (2016-2021)
6.3 United States Antihypertensive Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Antihypertensive Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Antihypertensive Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Antihypertensive Drugs Price by Type (2016-2021)
6.4 United States Antihypertensive Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Antihypertensive Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Antihypertensive Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Antihypertensive Drugs Price Forecast by Type (2022-2027)
6.5 United States Antihypertensive Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Antihypertensive Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Antihypertensive Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Antihypertensive Drugs Price by Application (2016-2021)
6.6 United States Antihypertensive Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Antihypertensive Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Antihypertensive Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Antihypertensive Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Antihypertensive Drugs Market Size YoY Growth 2016-2027
7.2 North America Antihypertensive Drugs Market Facts & Figures by Country
7.2.1 North America Antihypertensive Drugs Sales by Country (2016-2021)
7.2.2 North America Antihypertensive Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Antihypertensive Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Antihypertensive Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Antihypertensive Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Antihypertensive Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Antihypertensive Drugs Market Size YoY Growth 2016-2027
9.2 Europe Antihypertensive Drugs Market Facts & Figures by Country
9.2.1 Europe Antihypertensive Drugs Sales by Country (2016-2021)
9.2.2 Europe Antihypertensive Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Antihypertensive Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Antihypertensive Drugs Market Facts & Figures by Country
10.2.1 Latin America Antihypertensive Drugs Sales by Country (2016-2021)
10.2.2 Latin America Antihypertensive Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antihypertensive Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Antihypertensive Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Antihypertensive Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Antihypertensive Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Antihypertensive Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Antihypertensive Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Antihypertensive Drugs Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Description and Business Overview
12.4.3 Sanofi Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Antihypertensive Drugs Products Offered
12.4.5 Sanofi Recent Development
12.5 Lupin
12.5.1 Lupin Corporation Information
12.5.2 Lupin Description and Business Overview
12.5.3 Lupin Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Lupin Antihypertensive Drugs Products Offered
12.5.5 Lupin Recent Development
12.6 Ranbaxy Laboratories
12.6.1 Ranbaxy Laboratories Corporation Information
12.6.2 Ranbaxy Laboratories Description and Business Overview
12.6.3 Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ranbaxy Laboratories Antihypertensive Drugs Products Offered
12.6.5 Ranbaxy Laboratories Recent Development
12.7 Merck
12.7.1 Merck Corporation Information
12.7.2 Merck Description and Business Overview
12.7.3 Merck Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck Antihypertensive Drugs Products Offered
12.7.5 Merck Recent Development
12.8 Astra Zeneca
12.8.1 Astra Zeneca Corporation Information
12.8.2 Astra Zeneca Description and Business Overview
12.8.3 Astra Zeneca Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Astra Zeneca Antihypertensive Drugs Products Offered
12.8.5 Astra Zeneca Recent Development
12.9 Daiichi Sankyo
12.9.1 Daiichi Sankyo Corporation Information
12.9.2 Daiichi Sankyo Description and Business Overview
12.9.3 Daiichi Sankyo Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Daiichi Sankyo Antihypertensive Drugs Products Offered
12.9.5 Daiichi Sankyo Recent Development
12.10 Takeda
12.10.1 Takeda Corporation Information
12.10.2 Takeda Description and Business Overview
12.10.3 Takeda Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Takeda Antihypertensive Drugs Products Offered
12.10.5 Takeda Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Antihypertensive Drugs Products Offered
12.11.5 Novartis Recent Development
12.12 United Therapeutics
12.12.1 United Therapeutics Corporation Information
12.12.2 United Therapeutics Description and Business Overview
12.12.3 United Therapeutics Antihypertensive Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 United Therapeutics Products Offered
12.12.5 United Therapeutics Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Antihypertensive Drugs Industry Trends
13.2 Antihypertensive Drugs Market Drivers
13.3 Antihypertensive Drugs Market Challenges
13.4 Antihypertensive Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antihypertensive Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Antihypertensive Drugs Market Insights, Forecast to 2027
List of TablesTable 1. Global Antihypertensive Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Diuretic Antihypertensive
Table 3. Major Manufacturers of Sympathetic Suppressant
Table 4. Major Manufacturers of Renin-angiotensin System Inhibitor
Table 5. Major Manufacturers of Calcium Antagonist Medicine
Table 6. Major Manufacturers of vasodilator
Table 7. Global Antihypertensive Drugs Market Size Growth Rate by Application (2021-2027) & (M Pcs)
Table 8. Global Antihypertensive Drugs Market Size by Region (M Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Antihypertensive Drugs Sales by Regions (2016-2021) & (M Pcs)
Table 10. Global Antihypertensive Drugs Sales Market Share by Regions (2016-2021)
Table 11. Global Antihypertensive Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Antihypertensive Drugs Sales Forecast by Region (2022-2027) & (M Pcs)
Table 13. Global Antihypertensive Drugs Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Antihypertensive Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Antihypertensive Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Antihypertensive Drugs Sales by Manufacturers (2016-2021) (M Pcs)
Table 17. Global Antihypertensive Drugs Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Antihypertensive Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 19. Antihypertensive Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Antihypertensive Drugs Revenue Share by Manufacturers (2016-2021)
Table 21. Global Antihypertensive Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Antihypertensive Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihypertensive Drugs as of 2020)
Table 23. Key Manufacturers Antihypertensive Drugs Price (2016-2021) (USD/K Pcs)
Table 24. Antihypertensive Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Antihypertensive Drugs Product Type
Table 26. Date of International Manufacturers Enter into Antihypertensive Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Antihypertensive Drugs Sales by Type (2016-2021) (M Pcs)
Table 29. Global Antihypertensive Drugs Sales Share by Type (2016-2021)
Table 30. Global Antihypertensive Drugs Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Antihypertensive Drugs Revenue Share by Type (2016-2021)
Table 32. Antihypertensive Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/K Pcs)
Table 33. Global Antihypertensive Drugs Sales Forecast by Type (2022-2027) & (M Pcs)
Table 34. Global Antihypertensive Drugs Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Antihypertensive Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Antihypertensive Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Antihypertensive Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/K Pcs)
Table 38. Global Antihypertensive Drugs Sales by Application (2016-2021) (M Pcs)
Table 39. Global Antihypertensive Drugs Sales Share by Application (2016-2021)
Table 40. Global Antihypertensive Drugs Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Antihypertensive Drugs Revenue Share by Application (2016-2021)
Table 42. Antihypertensive Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/K Pcs)
Table 43. Global Antihypertensive Drugs Sales Forecast by Application (2022-2027) & (M Pcs)
Table 44. Global Antihypertensive Drugs Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Antihypertensive Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Antihypertensive Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Antihypertensive Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/K Pcs)
Table 48. United States Antihypertensive Drugs Sales (M Pcs) of Key Companies (2016-2021)
Table 49. United States Antihypertensive Drugs Sales Share by Company (2016-2021)
Table 50. United States Antihypertensive Drugs Revenue (US$ Million) by Company (2016-2021)
Table 51. United States Antihypertensive Drugs Revenue Share by Company (2016-2021)
Table 52. United States Antihypertensive Drugs Sales (M Pcs) by Type (2016-2021)
Table 53. United States Antihypertensive Drugs Sales Share by Type (2016-2021)
Table 54. United States Antihypertensive Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. United States Antihypertensive Drugs Price (USD/K Pcs) by Type (2016-2021)
Table 56. United States Antihypertensive Drugs Sales (M Pcs) by Type (2022-2027)
Table 57. United States Antihypertensive Drugs Sales Share by Type (2022-2027)
Table 58. United States Antihypertensive Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. United States Antihypertensive Drugs Revenue Share by Type (2022-2027)
Table 60. United States Antihypertensive Drugs Price (USD/K Pcs) by Type (2022-2027)
Table 61. United States Antihypertensive Drugs Sales (M Pcs) by Application (2016-2021)
Table 62. United States Antihypertensive Drugs Sales Share by Application (2016-2021)
Table 63. United States Antihypertensive Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. United States Antihypertensive Drugs Price (USD/K Pcs) by Application (2016-2021)
Table 65. United States Antihypertensive Drugs Sales (M Pcs) by Application (2022-2027)
Table 66. United States Antihypertensive Drugs Sales Share by Application (2022-2027)
Table 67. United States Antihypertensive Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. United States Antihypertensive Drugs Revenue Share by Application (2022-2027)
Table 69. United States Antihypertensive Drugs Price (USD/K Pcs) by Application (2022-2027)
Table 70. North America Antihypertensive Drugs Sales by Country (2016-2021) & (M Pcs)
Table 71. North America Antihypertensive Drugs Sales Market Share by Country (2016-2021)
Table 72. North America Antihypertensive Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Antihypertensive Drugs Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Antihypertensive Drugs Sales by Region (2016-2021) & (M Pcs)
Table 75. Asia Pacific Antihypertensive Drugs Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Antihypertensive Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Antihypertensive Drugs Revenue Market Share by Region (2016-2021)
Table 78. Europe Antihypertensive Drugs Sales by Country (2016-2021) & (M Pcs)
Table 79. Europe Antihypertensive Drugs Sales Market Share by Country (2016-2021)
Table 80. Europe Antihypertensive Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Antihypertensive Drugs Revenue Market Share by Country (2016-2021)
Table 82. Latin America Antihypertensive Drugs Sales by Country (2016-2021) & (M Pcs)
Table 83. Latin America Antihypertensive Drugs Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Antihypertensive Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Antihypertensive Drugs Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Antihypertensive Drugs Sales by Country (2016-2021) & (M Pcs)
Table 87. Middle East and Africa Antihypertensive Drugs Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Antihypertensive Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Antihypertensive Drugs Revenue Market Share by Country (2016-2021)
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 93. Novartis Antihypertensive Drugs Product
Table 94. Novartis Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 103. Johnson & Johnson Product
Table 104. Johnson & Johnson Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 108. Sanofi Product
Table 109. Sanofi Recent Development
Table 110. Lupin Corporation Information
Table 111. Lupin Description and Business Overview
Table 112. Lupin Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 113. Lupin Product
Table 114. Lupin Recent Development
Table 115. Ranbaxy Laboratories Corporation Information
Table 116. Ranbaxy Laboratories Description and Business Overview
Table 117. Ranbaxy Laboratories Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 118. Ranbaxy Laboratories Product
Table 119. Ranbaxy Laboratories Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 123. Merck Product
Table 124. Merck Recent Development
Table 125. Astra Zeneca Corporation Information
Table 126. Astra Zeneca Description and Business Overview
Table 127. Astra Zeneca Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 128. Astra Zeneca Product
Table 129. Astra Zeneca Recent Development
Table 130. Daiichi Sankyo Corporation Information
Table 131. Daiichi Sankyo Description and Business Overview
Table 132. Daiichi Sankyo Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 133. Daiichi Sankyo Product
Table 134. Daiichi Sankyo Recent Development
Table 135. Takeda Corporation Information
Table 136. Takeda Description and Business Overview
Table 137. Takeda Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 138. Takeda Product
Table 139. Takeda Recent Development
Table 140. Actelion Corporation Information
Table 141. Actelion Description and Business Overview
Table 142. Actelion Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 143. Actelion Product
Table 144. Actelion Recent Development
Table 145. United Therapeutics Corporation Information
Table 146. United Therapeutics Description and Business Overview
Table 147. United Therapeutics Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021)
Table 148. United Therapeutics Product
Table 149. United Therapeutics Recent Development
Table 150. Antihypertensive Drugs Market Trends
Table 151. Antihypertensive Drugs Market Drivers
Table 152. Antihypertensive Drugs Market Challenges
Table 153. Antihypertensive Drugs Market Restraints
Table 154. Antihypertensive Drugs Customers List
Table 155. Antihypertensive Drugs Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Antihypertensive Drugs Product Picture
Figure 2. Global Antihypertensive Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Diuretic Antihypertensive Product Picture
Figure 4. Sympathetic Suppressant Product Picture
Figure 5. Renin-angiotensin System Inhibitor Product Picture
Figure 6. Calcium Antagonist Medicine Product Picture
Figure 7. vasodilator Product Picture
Figure 8. Global Antihypertensive Drugs Sales Market Share by Application in 2020 & 2027
Figure 9. The Old
Figure 10. Pregnant Woman
Figure 11. General Patient
Figure 12. Antihypertensive Drugs Report Years Considered
Figure 13. Global Antihypertensive Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Antihypertensive Drugs Market Size 2016-2027 (US$ Million)
Figure 15. Global Antihypertensive Drugs Sales 2016-2027 (M Pcs)
Figure 16. Global Antihypertensive Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Antihypertensive Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Antihypertensive Drugs Sales Market Share by Region in 2020
Figure 19. Global Antihypertensive Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Antihypertensive Drugs Revenue Market Share by Region in 2020
Figure 21. Global Antihypertensive Drugs Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Antihypertensive Drugs Revenue in 2020
Figure 23. Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Antihypertensive Drugs Sales Market Share by Type (2016-2021)
Figure 25. Global Antihypertensive Drugs Sales Market Share by Type in 2020
Figure 26. Global Antihypertensive Drugs Revenue Market Share by Type (2016-2021)
Figure 27. Global Antihypertensive Drugs Revenue Market Share by Type in 2020
Figure 28. Global Antihypertensive Drugs Sales Market Share by Application (2016-2021)
Figure 29. Global Antihypertensive Drugs Sales Market Share by Application in 2020
Figure 30. Global Antihypertensive Drugs Revenue Market Share by Application (2016-2021)
Figure 31. Global Antihypertensive Drugs Revenue Market Share by Application in 2020
Figure 32. United States Antihypertensive Drugs Sales Growth Rate 2016-2027 (M Pcs)
Figure 33. United States Antihypertensive Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. United States Antihypertensive Drugs Market Share in Global Market 2016-2027
Figure 35. United States 5 and 10 Largest Antihypertensive Drugs Players Market Share by Revenue in Antihypertensive Drugs in 2020
Figure 36. United States Antihypertensive Drugs Revenue Share by Type (2016-2021)
Figure 37. United States Antihypertensive Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 38. United States Antihypertensive Drugs Revenue Share by Application (2016-2021)
Figure 39. United States Antihypertensive Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Antihypertensive Drugs Sales Growth Rate 2016-2021 (M Pcs)
Figure 41. North America Antihypertensive Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Antihypertensive Drugs Sales Market Share by Country in 2020
Figure 43. North America Antihypertensive Drugs Revenue Market Share by Country in 2020
Figure 44. U.S. Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 45. U.S. Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 47. Canada Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Antihypertensive Drugs Sales Growth Rate 2016-2021 (M Pcs)
Figure 49. Europe Antihypertensive Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Antihypertensive Drugs Sales Market Share by Country in 2020
Figure 51. Europe Antihypertensive Drugs Revenue Market Share by Country in 2020
Figure 52. Germany Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 53. Germany Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 55. France Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 57. U.K. Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 59. Italy Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 61. Russia Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific Antihypertensive Drugs Sales Growth Rate 2016-2021 (M Pcs)
Figure 63. Asia Pacific Antihypertensive Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific Antihypertensive Drugs Sales Market Share by Region in 2020
Figure 65. Asia Pacific Antihypertensive Drugs Revenue Market Share by Region in 2020
Figure 66. China Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 67. China Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 69. Japan Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 71. South Korea Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. India Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 73. India Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Australia Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 75. Australia Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Taiwan Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 77. Taiwan Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Indonesia Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 79. Indonesia Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Thailand Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 81. Thailand Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Malaysia Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 83. Malaysia Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Philippines Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 85. Philippines Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Vietnam Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 87. Vietnam Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Latin America Antihypertensive Drugs Sales Growth Rate 2016-2021 (M Pcs)
Figure 89. Latin America Antihypertensive Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 90. Latin America Antihypertensive Drugs Sales Market Share by Country in 2020
Figure 91. Latin America Antihypertensive Drugs Revenue Market Share by Country in 2020
Figure 92. Mexico Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 93. Mexico Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Brazil Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 95. Brazil Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Argentina Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 97. Argentina Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Middle East and Africa Antihypertensive Drugs Sales Growth Rate 2016-2021 (M Pcs)
Figure 99. Middle East and Africa Antihypertensive Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 100. Middle East and Africa Antihypertensive Drugs Sales Market Share by Country in 2020
Figure 101. Middle East and Africa Antihypertensive Drugs Revenue Market Share by Country in 2020
Figure 102. Turkey Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 103. Turkey Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Saudi Arabia Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 105. Saudi Arabia Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. U.A.E Antihypertensive Drugs Sales Growth Rate (2016-2021) (M Pcs)
Figure 107. U.A.E Antihypertensive Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. Antihypertensive Drugs Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
Keyplayers in Global and United States Antihypertensive Drugs Market Insights, Forecast to 2027
NovartisPfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
Astra Zeneca
Daiichi Sankyo
Takeda
Actelion
United Therapeutics